Flex24 Pain Pen
NDC Package 54641-003-02
Package Information
Flex24 Pain Pen is adults and children over the age of 12:• Remove plastic top from device and put aside till after treatment• Apply liniment to affected area• Repeat as necessary but no more than 3 treatments per day• Children under 12, consult a doctor before use. Marketed by Larasan Pharmaceutical Corporation, this product is identified by NDC 54641-003 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1365674 - camphor 7.79 % Topical Solution
- RxCUI: 1365674 - camphor 0.779 MG/ML Topical Solution
- RxCUI: 1601550 - Flex24 Pain Pen 7.79 % Topical Solution
- RxCUI: 1601550 - camphor 0.779 MG/ML Topical Solution [Flex24]
- RxCUI: 1601550 - Flex24 0.779 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54641 - Larasan Pharmaceutical Corporation
- 54641-003 - Flex24 Pain Pen
- 54641-003-02 - 18 mL in 1 BOTTLE, WITH APPLICATOR
- 54641-003 - Flex24 Pain Pen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54641-003-02 identifies a specific commercial package of 18 ml in 1 bottle, with applicator of Flex24 Pain Pen, labeled by Larasan Pharmaceutical Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 18 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Larasan Pharmaceutical Corporation on February 10, 2015. The current certification is valid through December 31, 2020.
How is this Larasan Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54641000302. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 18 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.